Stryker Corporation (SYK) : Crestwood Advisors scooped up 6,520 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 195,984 shares of Stryker Corporation which is valued at $22,649,871.Stryker Corporation makes up approximately 2.51% of Crestwood Advisors’s portfolio.
Other Hedge Funds, Including , Paloma Partners Management Co reduced its stake in SYK by selling 36,211 shares or 62.23% in the most recent quarter. The Hedge Fund company now holds 21,980 shares of SYK which is valued at $2,540,229. Stryker Corporation makes up approx 0.10% of Paloma Partners Management Co’s portfolio.Nuveen Asset Management boosted its stake in SYK in the latest quarter, The investment management firm added 302 additional shares and now holds a total of 25,479 shares of Stryker Corporation which is valued at $2,944,608. Stryker Corporation makes up approx 0.02% of Nuveen Asset Management’s portfolio.Pioneer Investment Management Inc boosted its stake in SYK in the latest quarter, The investment management firm added 6,306 additional shares and now holds a total of 43,865 shares of Stryker Corporation which is valued at $5,069,478. Stryker Corporation makes up approx 0.02% of Pioneer Investment Management Inc’s portfolio.Compass Capital Management Inc reduced its stake in SYK by selling 9,872 shares or 4.95% in the most recent quarter. The Hedge Fund company now holds 189,434 shares of SYK which is valued at $22,027,386. Stryker Corporation makes up approx 4.12% of Compass Capital Management Inc’s portfolio.
Stryker Corporation closed down -0.43 points or -0.37% at $115.23 with 9,39,405 shares getting traded on Thursday. Post opening the session at $115.9, the shares hit an intraday low of $114.41 and an intraday high of $115.9 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.
Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.